Skip to main content

Spinal Muscular Atrophy: Medical Treatments

Question for Department of Health and Social Care

UIN 130464, tabled on 28 February 2018

To ask the Secretary of State for Health and Social Care, what the timetable is for the NICE appraisal of Spinraza for the treatment of spinal muscular atrophy.

Answered on

5 March 2018

The National Institute for Health and Care Excellence currently expects to issue final guidance on the use of nusinersen for the treatment of spinal muscular atrophy in November 2018, with a first Appraisal Committee meeting to discuss the topic scheduled for 26 June 2018.

Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.